Skip to content

Optimization of new endoscopic screening technology

Colorectal cancer screening and intervention in China

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028511
Enrollment
Unknown
Registered
2019-12-24
Start date
2017-07-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal tumor

Interventions

Gold Standard:Pathological results

Sponsors

The Sixth Affiliated Hospital Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male or female outpatients of national legal age with informed consent for adults aged 45 to 80 years; 2. Patients with positive primary screening or physical examination of colorectal cancer to be examined by awake enteroscopy.

Exclusion criteria

Exclusion criteria: 1. Endoscopy within 1 year; 2. Previous abdominal and pelvic surgery history; 3. Previous radiotherapy history of abdomen and pelvis; 4. There is clear active lower gastrointestinal bleeding; 5. Existing or suspected hereditary colorectal polyposis, inflammatory bowel disease or inflammatory bowel disease; 6. Uncontrolled hypertension (untreated systolic > 160 mmHg, or diastolic > 95 mmHg); 7. History of stroke, coronary artery disease or vascular disease; 8. Pregnant; 9. No bowel preparation; 10. Refusal to undergo a conscious enteroscopy.

Design outcomes

Primary

MeasureTime frame
Proximal Colon Adenoma detection rate;

Countries

China

Contacts

Public ContactHe Xiaosheng

The Sixth Affiliated Hospital Sun Yat-sen University

15545585@qq.com+86 15918779711

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026